26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 4: systemic hypertension.
作者信息
Kaplan N M, Deveraux R B, Miller H S
出版信息
J Am Coll Cardiol. 1994 Oct;24(4):885-8. doi: 10.1016/0735-1097(94)90845-1.
PMID:7930221
Abstract
摘要
相似文献
1
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 4: systemic hypertension.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。第4工作组：系统性高血压。
J Am Coll Cardiol. 1994 Oct;24(4):885-8. doi: 10.1016/0735-1097(94)90845-1.
2
3
4
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。特别工作组2：获得性瓣膜性心脏病。
J Am Coll Cardiol. 1994 Oct;24(4):874-80. doi: 10.1016/0735-1097(94)90843-5.
5
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 5: coronary artery disease.
J Am Coll Cardiol. 1994 Oct;24(4):888-92. doi: 10.1016/0735-1097(94)90846-x.
6
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 5: coronary artery disease.
Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S271-5.
7
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 6: arrhythmias.
J Am Coll Cardiol. 1994 Oct;24(4):892-9. doi: 10.1016/0735-1097(94)90847-8.
8
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 6: arrhythmias.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。第6工作组：心律失常
Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S276-83.
9
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。第3工作组：肥厚型心肌病、心肌炎及其他心肌心包疾病与二尖瓣脱垂
J Am Coll Cardiol. 1994 Oct;24(4):880-5. doi: 10.1016/0735-1097(94)90844-3.
10
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。第3工作组：肥厚型心肌病、心肌炎及其他心肌心包疾病和二尖瓣脱垂。
Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S261-7.
引用本文的文献
1
Exercise-induced arterial hypertension - an independent factor for hypertrophy and a ticking clock for cardiac fatigue or atrial fibrillation in athletes?运动诱发的动脉高血压——运动员心肌肥厚的独立因素以及心脏疲劳或心房颤动的定时炸弹？
F1000Res. 2014 May 12;3:105. doi: 10.12688/f1000research.4001.1. eCollection 2014.
Zotero 插件